Oncolytic Supply Partner Network

The API Innovation Center (APIIC) and its strategic partners have formed the Oncolytic Supply Partner Network. This network follows a call for collective action to identify and prioritize drug products of the highest importance and greatest patient impact in the U.S. The API Innovation Center is taking action and is engaging in strategic partnerships to leverage connections with key organizations to address this national health crisis. 


What is the OSPN?

The OSPN will work together to produce critical oncology drugs using innovative advanced technologies to ensure a reliable U.S.-based supply for cancer patients. The network will identify and prioritize critical cancer drugs of the highest importance and greatest patient impact.

Objectives of the Oncolytic Supply Partner Network:

A Public-Private Partnership to Secure U.S. Patient Supply of Oncolytics


Identify and prioritize drug products of the highest importance and of greatest patient impact.


Secure and deploy funding (federal, state, commercial) for the de-risking of advanced manufacturing technology.


Manage the development, manufacturing, and approval of API and Drug Products with strategic partners.


Engage policymakers and administration to allocate and prioritize resources for oncology drug production.


Manage the national distribution and coordinate health system pull-through.

Are you a manufacturer interested in being part of the OSPN?

Contact us today.